No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial.

por Marlous L Grijsen, Radjin Steingrover, Ferdinand W N M Wit, Suzanne Jurriaans, Annelies Verbon, Kees Brinkman, Marchina E van der Ende, Robin Soetekouw, Frank de Wolf, Joep M A Lange, Hanneke Schuitemaker, Jan M Prins, Primo-SHM Study Group
Publicado 2012